fashion -WSS

fashion

author：focus 2025-09-28 00:52:13 - browse：266

Doctors perform bariatric surgery at a hospital in Tijuana, Mexico. GUILLERMO ARIAS/AFP via Getty Images

Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery.

For obesity, surgery has long been — and continues to be — the most effective treatment, reducing patients’ risk of sleep apnea, diabetes, cancer, cardiovascular disease, and death. However, the gap between weight loss drugs and bariatric surgery is starting to narrow after Wegovy cut the risk of major heart complications by 20% in Novo Nordisk’s SELECT trial.

“Personally, I would have taken a 5% reduction,” said Angela Fitch, president of the Obesity Medicine Association, emphasizing that these results symbolize a paradigm shift in obesity medicine. With even more effective weight loss drugs already emerging and other clinical trial evidence on the horizon, the hope is that, with medication, “we would see similar sorts of outcomes that we see with surgery,” said Fitch.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： He's a Nobel laureate. Critics say he was misleading on Covid

WSS

After decades in use, heart stents finally beat placebo

PBM reform efforts get punted in Congress

What is STAT's opinion section for?

Obesity drugs seen as possible treatment for liver disease MASH

A new nitrogen execution bill also undermines medical licensing

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Wikipedia

fashion

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

With competition flaring, obesity drug hits goal in liver disease study

Apple is now the first public company to be valued at $3 trillion

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Supreme Court strikes down use of affirmative action

Medicare’s new pay boost for primary care is angering specialists

FDA approval of Sarepta Duchenne genetic therapy gives me hope

After decades in use, heart stents finally beat placebo

Anesthesiologist group: stop taking Ozempic before surgery

NIH study of ME/CFS points to clear biological hallmarks

hotspot

Medical school prerequisites are outdated

Publishing genetic code of viruses could cause disaster

The Harvard botanist who searched for psychedelics in the Amazon

6 phony surgeries that take placebo to the extreme

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Experimental asthma app from Apple and Anthem shows promise

hotspot

focus

hotspot

entertainment